LJ
Insider
Leon O Moulder Jr
See RemarksLeon O Moulder Jr (See Remarks) filed 6 Form 4 reports in the trailing twelve months (6 purchases, 0 sales), most often in Zenas BioPharma, Inc. (ZBIO). Across 6 priced purchase filings, the average 21-session return was +16.6% from execution and +16.3% from disclosure (delay-adjusted; derived). The largest single filing was $1.6M of ZBIO (100,000 sh across 3 lots, as filed), executed Jan 7.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+16.6%
avg across 6 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+16.3%
same 6 filings, from disclosure
Filings, ttm
6
6 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.5M
shares × price, as filed
Last traded
May 18
Filed May 18
Impact on $10,000 · 12M
$18,768 (+87.7%)
S&P 500 $11,725 (+17.2%) · 70.4 pts ahead
Leon O Moulder Jr
S&P 500
Compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $7.5M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
ZBIORecent filings
ZBIOPURCHASE
Zenas BioPharma, Inc.
View filing →
$112K7,500 sh × $15.00
Exec Nov 18 2024
Filed Nov 20 2024 · 5:30 PM ET ZBIOPURCHASE Zenas BioPharma, Inc. View filing → $179K
10,000 sh × $17.91
Exec Sep 18 2024
Filed Sep 20 2024 · 5:30 PM ET